Bank of New York Mellon’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $791K | Buy |
|
|||||
|
2025
Q1 | $762K | Sell |
|
|||||
|
2024
Q4 | $1.18M | Buy |
|
|||||
|
2024
Q3 | $883K | Buy |
|
|||||
|
2024
Q2 | $411K | Buy |
|
|||||
|
2024
Q1 | $663K | Sell |
|
|||||
|
2023
Q4 | $568K | Buy |
|
|||||
|
2023
Q3 | $451K | Sell |
|
|||||
|
2023
Q2 | $645K | Buy |
|
|||||
|
2023
Q1 | $689K | Sell |
|
|||||
|
2022
Q4 | $680K | Buy |
|
|||||
|
2022
Q3 | $716K | Buy |
|
|||||
|
2022
Q2 | $679K | Sell |
|
|||||
|
2022
Q1 | $1.04M | Buy |
|
|||||
|
2021
Q4 | $653K | Buy |
|
|||||
|
2021
Q3 | $621K | Buy |
|